Protective Effect of Calpain Inhibition During Cold Ischemia on Ischemia–reperfusion Injury After Lung Transplantation

Abstract

Background. Necroptosis, one of the types of regulated necrosis, causes ischemia–reperfusion (IR) lung injury. N-acetyl-leucyl-leucyl-norleucinal (ALLN), a calpain inhibitor, is known to attenuate necroptosis and apoptosis, and the purpose of this study was to evaluate the protective effect of ALLN during cold ischemia against IR injury in a rat lung transplant model. Methods. Male Lewis rats (250–350 g) were divided into 3 groups: sham group (n = 4), nontransplantation; control group (n = 8), transplantation with IR lung injury; and ALLN group (n = 8), transplantation with IR lung injury/ALLN. Rats in the sham group underwent a simple thoracotomy, and the remaining 2 groups of rats underwent an orthotopic left lung transplant. Cold ischemic time was 15 h. After 2 h of reperfusion, physiological function, inflammatory cytokine expression, pathway activation, and the degrees of necroptosis and apoptosis were evaluated. Results. Lung gas exchange (PaO2/FiO2) was significantly better, and pulmonary edema was significantly improved in the ALLN group compared with the control group (P = 0.0009, P = 0.0014). Plasma expression of interleukin-1β was significantly lower in the ALLN group than in the control group (P = 0.0313). The proportion of necroptotic and apoptotic cells was significantly lower in the ALLN group than in the control group (P = 0.0009), whereas the proportion of apoptotic cells remained unchanged (P = 0.372); therefore, the calpain inhibitor was thought to suppress necroptosis. Conclusions. The administration of ALLN during cold ischemia appears to improve IR lung injury in a lung transplant animal model via the inhibition of necroptosis.